Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 382

Similar articles for PubMed (Select 17914397)

1.

Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers.

Binshtok AM, Bean BP, Woolf CJ.

Nature. 2007 Oct 4;449(7162):607-10.

PMID:
17914397
2.

Neuroscience: a local route to pain relief.

McCleskey EW.

Nature. 2007 Oct 4;449(7162):545-6. No abstract available.

PMID:
17914381
3.

Acid solution is a suitable medium for introducing QX-314 into nociceptors through TRPV1 channels to produce sensory-specific analgesic effects.

Liu H, Zhang HX, Hou HY, Lu XF, Wei JQ, Wang CG, Zhang LC, Zeng YM, Wu YP, Cao JL.

PLoS One. 2011;6(12):e29395. doi: 10.1371/journal.pone.0029395. Epub 2011 Dec 28.

4.

Targeting of sodium channel blockers into nociceptors to produce long-duration analgesia: a systematic study and review.

Roberson DP, Binshtok AM, Blasl F, Bean BP, Woolf CJ.

Br J Pharmacol. 2011 Sep;164(1):48-58. doi: 10.1111/j.1476-5381.2011.01391.x. Review.

5.

Emulsified isoflurane enhances thermal transient receptor potential vanilloid-1 channel activation-mediated sensory/nociceptive blockade by QX-314.

Zhou C, Liang P, Liu J, Zhang W, Liao D, Chen Y, Chen X, Li T.

Anesthesiology. 2014 Aug;121(2):280-9. doi: 10.1097/ALN.0000000000000236.

PMID:
24667830
6.

Selectively targeting pain in the trigeminal system.

Kim HY, Kim K, Li HY, Chung G, Park CK, Kim JS, Jung SJ, Lee MK, Ahn DK, Hwang SJ, Kang Y, Binshtok AM, Bean BP, Woolf CJ, Oh SB.

Pain. 2010 Jul;150(1):29-40. doi: 10.1016/j.pain.2010.02.016. Epub 2010 Mar 16.

PMID:
20236764
7.

Coapplication of lidocaine and the permanently charged sodium channel blocker QX-314 produces a long-lasting nociceptive blockade in rodents.

Binshtok AM, Gerner P, Oh SB, Puopolo M, Suzuki S, Roberson DP, Herbert T, Wang CF, Kim D, Chung G, Mitani AA, Wang GK, Bean BP, Woolf CJ.

Anesthesiology. 2009 Jul;111(1):127-37. doi: 10.1097/ALN.0b013e3181a915e7.

8.

Expression of TRPV1 channels after nerve injury provides an essential delivery tool for neuropathic pain attenuation.

Zakir HM, Mostafeezur RM, Suzuki A, Hitomi S, Suzuki I, Maeda T, Seo K, Yamada Y, Yamamura K, Lev S, Binshtok AM, Iwata K, Kitagawa J.

PLoS One. 2012;7(9):e44023. doi: 10.1371/journal.pone.0044023. Epub 2012 Sep 4.

9.

Phenotyping the function of TRPV1-expressing sensory neurons by targeted axonal silencing.

Brenneis C, Kistner K, Puopolo M, Segal D, Roberson D, Sisignano M, Labocha S, Ferreirós N, Strominger A, Cobos EJ, Ghasemlou N, Geisslinger G, Reeh PW, Bean BP, Woolf CJ.

J Neurosci. 2013 Jan 2;33(1):315-26. doi: 10.1523/JNEUROSCI.2804-12.2013.

10.

Characterization of dental nociceptive neurons.

Kim HY, Chung G, Jo HJ, Kim YS, Bae YC, Jung SJ, Kim JS, Oh SB.

J Dent Res. 2011 Jun;90(6):771-6. doi: 10.1177/0022034511399906. Epub 2011 Mar 1.

PMID:
21364091
11.
12.

Bupivacaine-induced cellular entry of QX-314 and its contribution to differential nerve block.

Brenneis C, Kistner K, Puopolo M, Jo S, Roberson D, Sisignano M, Segal D, Cobos EJ, Wainger BJ, Labocha S, Ferreirós N, von Hehn C, Tran J, Geisslinger G, Reeh PW, Bean BP, Woolf CJ.

Br J Pharmacol. 2014 Jan;171(2):438-51. doi: 10.1111/bph.12466.

13.

Permeation and block of TRPV1 channels by the cationic lidocaine derivative QX-314.

Puopolo M, Binshtok AM, Yao GL, Oh SB, Woolf CJ, Bean BP.

J Neurophysiol. 2013 Apr;109(7):1704-12. doi: 10.1152/jn.00012.2013. Epub 2013 Jan 9.

14.

TRPV1b overexpression negatively regulates TRPV1 responsiveness to capsaicin, heat and low pH in HEK293 cells.

Vos MH, Neelands TR, McDonald HA, Choi W, Kroeger PE, Puttfarcken PS, Faltynek CR, Moreland RB, Han P.

J Neurochem. 2006 Nov;99(4):1088-102.

PMID:
17018028
15.

QX-314 inhibits ectopic nerve activity associated with neuropathic pain.

Omana-Zapata I, Khabbaz MA, Hunter JC, Bley KR.

Brain Res. 1997 Oct 17;771(2):228-37.

PMID:
9401743
16.
17.

Lighting a backfire to quench the blaze: a combined drug approach targeting the vanilloid receptor TRPV1.

Blumberg PM.

Mol Interv. 2007 Dec;7(6):310-2. doi: 10.1124/mi.7.6.5. Review.

PMID:
18199852
18.

Inhibitor kappaB Kinase beta deficiency in primary nociceptive neurons increases TRP channel sensitivity.

Bockhart V, Constantin CE, Häussler A, Wijnvoord N, Kanngiesser M, Myrczek T, Pickert G, Popp L, Sobotzik JM, Pasparakis M, Kuner R, Geisslinger G, Schultz C, Kress M, Tegeder I.

J Neurosci. 2009 Oct 14;29(41):12919-29. doi: 10.1523/JNEUROSCI.1496-09.2009.

19.

External QX-314 inhibits evoked cranial primary afferent synaptic transmission independent of TRPV1.

Hofmann ME, Largent-Milnes TM, Fawley JA, Andresen MC.

J Neurophysiol. 2014 Dec 1;112(11):2697-706. doi: 10.1152/jn.00316.2014. Epub 2014 Sep 3.

PMID:
25185814
20.

Antinociceptive desensitizing actions of TRPV1 receptor agonists capsaicin, resiniferatoxin and N-oleoyldopamine as measured by determination of the noxious heat and cold thresholds in the rat.

Bölcskei K, Tékus V, Dézsi L, Szolcsányi J, Petho G.

Eur J Pain. 2010 May;14(5):480-6. doi: 10.1016/j.ejpain.2009.08.005. Epub 2009 Oct 1.

PMID:
19800272
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk